Stock Purchase Agreements in Healthcare Deals

2025-01-01

Dike Law Group PLLC

You’ve found a healthcare business you want to buy, or you’ve decided it’s time to sell the practice you spent years building. The deal is coming together. Then someone mentions a stock purchase agreement, and suddenly the room gets quiet.

For many physicians and healthcare entrepreneurs, the phrase “stock purchase agreement” triggers one of two reactions: either confusion about what it actually means or overconfidence that it’s a simple document any attorney can handle.

Both reactions carry risk. In healthcare transactions, a stock purchase agreement is not just a transfer of ownership. It carries with it compliance obligations, regulatory exposure, licensing implications, and financial liabilities that are unique to this industry. Getting it wrong can cost you the deal, expose you to federal investigations, or leave you holding liabilities you never agreed to take on.

This guide breaks down exactly how stock purchase agreements work in healthcare deals, what makes them different from other business transactions, and what you need to evaluate before signing anything. If you are navigating a healthcare acquisition in Texas or beyond, understanding this document is not optional.

Explore our Texas healthcare mergers and acquisitions services and our dedicated stock purchase agreement resources to understand the full scope of how we support deals like yours.

What Is a Stock Purchase Agreement in a Healthcare Context?

A stock purchase agreement (SPA) is a legal contract through which a buyer purchases the ownership shares of a company rather than its individual assets. In a healthcare setting, this means the buyer is acquiring the entity itself, whether that is a professional corporation, a management services organization, or a healthcare group.

When you buy stock, you are stepping into the seller’s shoes. You are acquiring everything the company owns and everything it owes. That includes:

• Revenue contracts and payor agreements
• Equipment and real property leases
• Staff employment agreements
• Existing Medicare and Medicaid provider numbers
• Outstanding compliance obligations
• Any undisclosed or historical liabilities

This is fundamentally different from an asset purchase agreement, where the buyer selects specific assets and generally avoids taking on unknown liabilities.

“In a stock deal, you are not just buying a business. You are buying its history. Every billing decision ever made, every contract ever signed, every compliance gap that was never addressed, it all comes with the acquisition.”

That history matters enormously in healthcare, where regulatory requirements, fraud and abuse laws, and licensing rules create layers of risk that simply do not exist in other industries.

See our deeper breakdown of how stock purchase agreements are structured and how they compare to asset purchases.

Why Do Healthcare Buyers Choose Stock Purchases?

If stock deals carry more risk, why would any buyer choose them? The answer comes down to practical advantages that asset purchases simply cannot offer.

Are there licensing and credentialing benefits?

Yes. One of the most significant reasons healthcare buyers choose stock purchases is to preserve existing provider relationships and credentialing. When you acquire stock rather than assets, Medicare and Medicaid provider numbers, managed care contracts, and payor credentialing can often transfer along with the entity.

In an asset deal, these relationships typically do not transfer. You would need to re-enroll with CMS, re-credential with payors, and re-apply for contracts that may take months to reestablish. For a practice that depends on insurance reimbursement, that gap in revenue can be devastating.

Does a stock deal preserve business continuity?

Often, yes. Employees, vendor relationships, and operational systems typically continue without interruption in a stock purchase. For buyers who want a turnkey acquisition, this is appealing. The business keeps operating, and the transition is smoother on paper.

What about tax treatment for sellers?

Sellers often prefer stock deals because they can benefit from capital gains treatment on proceeds rather than ordinary income rates that can apply in asset sales. This preference from the seller’s side means buyers negotiating stock deals sometimes have more leverage on price or terms.

However, buyers typically favor asset purchases for tax reasons, since they can step up the cost basis of acquired assets. This is one of the central negotiating tensions in healthcare M&A, and it is worth understanding before you enter any deal conversation.

For a broader look at the types of healthcare businesses available for acquisition, review our guide on ten types of healthcare businesses you should consider buying.

What Makes Healthcare Stock Purchases Legally Different From Other Industries?

Healthcare is one of the most regulated industries in the United States. Federal and state laws create obligations that follow the entity, not just the current owner. When you purchase stock in a healthcare company, you inherit compliance with all of these frameworks.

How do federal fraud and abuse laws apply to a stock deal?

The Stark Law and the Anti-Kickback Statute govern financial relationships in healthcare with significant consequences for violations. If the entity being acquired has existing arrangements that violate either law, the buyer inherits the exposure through a stock purchase.

The Anti-Kickback Statute, enforced by the Department of Justice and the HHS Office of Inspector General, prohibits any arrangement that involves remuneration in exchange for referrals of federal healthcare program business. Violations can trigger criminal liability and exclusion from Medicare and Medicaid.

The Stark Law prohibits physicians from referring patients for certain designated health services to entities with which the physician has a financial relationship, unless a specific exception applies.

Both frameworks require careful due diligence before any stock acquisition.

What about the False Claims Act?

The False Claims Act is one of the government’s most powerful tools to recover fraudulent billings to Medicare and Medicaid. If the entity being acquired submitted false claims before the transaction closed, those liabilities do not disappear with the change in ownership.

Our firm’s overview of the False Claims Act in healthcare explains how this statute can affect acquisitions and ongoing operations.

How does HIPAA affect a stock purchase?

The Health Insurance Portability and Accountability Act (HIPAA) governs protected health information (PHI). In a stock deal, the entity’s HIPAA compliance history, breach history, and Business Associate Agreements all transfer to the new owner.

If the entity has had prior breaches, inadequate policies, or improperly structured agreements with vendors, the buyer takes on the risk of regulatory enforcement and potential penalties from the HHS Office for Civil Rights.

Learn how compliance intersects with acquisitions through our resources on healthcare compliance in Dallas and our content on evaluating compliance risks in a healthcare acquisition.

What Should a Healthcare Stock Purchase Agreement Include?

A well-drafted healthcare SPA is comprehensive, specific, and protective. Below are the key provisions that should appear in any healthcare stock purchase agreement.

Representations and Warranties

Representations and warranties are statements of fact made by the seller about the business being sold. In healthcare deals, these should go beyond standard business reps to include specific healthcare-related warranties, such as:

• The entity is enrolled in Medicare and Medicaid and has not received a notice of exclusion or debarment
• All billing and coding practices comply with applicable federal and state laws
• No governmental investigations or audits are pending or threatened
• All employees and independent contractors have current, valid licenses
• The entity has complied with HIPAA and has a current, documented compliance program
• No material healthcare contracts are in default
• All required licenses and permits are valid and in good standing

If any of these representations turn out to be false, the indemnification provisions give the buyer the ability to seek compensation from the seller.

Indemnification Provisions

Indemnification clauses define who is responsible for costs that arise from pre-closing issues. In a stock deal, robust indemnification is critical because the buyer inherits the entity’s history.

A well-structured indemnification provision should address:

• The survival period for representations and warranties
• Caps on indemnification liability
• Baskets or deductibles before indemnification triggers
• Specific carve-outs for fraud, intentional misconduct, or regulatory violations

In healthcare, it is common to negotiate extended survival periods for healthcare-specific representations because investigations and audits from CMS or the OIG can arise years after a transaction closes.

Covenants and Closing Conditions

Covenants govern what each party must do between signing and closing. Common covenants in healthcare deals include:

• The seller must continue operating the business in the ordinary course
• Neither party can take actions that would trigger regulatory review
• The seller must notify the buyer of any new investigations, audits, or material adverse events

Closing conditions specify what must happen before the deal can close. In healthcare, these often include obtaining regulatory approvals, securing payor consent for change-of-control provisions, and confirming no material adverse change has occurred.

Purchase Price and Adjustment Mechanisms

The purchase price section should address not just the headline number but also the mechanisms that can adjust it, including:

• Escrow arrangements to cover potential indemnification claims
• Earn-out structures tied to future revenue performance
• Working capital adjustments based on the company’s financial condition at closing

Understanding how earn-out agreements work in healthcare is essential if the seller insists on tying part of the purchase price to future performance metrics.

Non-Compete and Restrictive Covenants

Sellers in healthcare deals are typically asked to sign non-compete agreements that restrict them from opening competing practices or soliciting former patients and staff for a defined period and geographic area.

Texas law on physician non-competes has specific requirements. Review our analysis of physician non-compete agreement requirements in Texas to understand what is enforceable and what is not.

What Is the Due Diligence Process for a Healthcare Stock Purchase?

Due diligence is the buyer’s investigation of the business before the deal closes. In healthcare, it is more extensive than in most other industries because the regulatory exposure is greater and the consequences of missing something are more severe.

What documents should a buyer request?

A thorough healthcare due diligence request list should include:

• All Medicare and Medicaid enrollment records and correspondence
• Billing and coding audit reports from the past three to five years
• HIPAA compliance policies, breach logs, and Business Associate Agreements
• All licenses, permits, and certifications for the entity and its practitioners
• Employment agreements, independent contractor agreements, and credentialing records
• Managed care and payor contracts, including any change-of-control clauses
• Corporate documents: articles of incorporation, bylaws, shareholder agreements, and ownership records
• Prior investigations, audits, complaints, or governmental inquiries
• Financial statements for three to five years
• Pending or threatened litigation

Our step-by-step guide on buying a medical practice in Texas walks through the due diligence process in detail.

What are the most common deal-breakers discovered during due diligence?

In our experience working with healthcare buyers across Texas, the most common due diligence findings that derail deals or require significant restructuring include:

• Undisclosed Medicare or Medicaid audits or overpayment demands
• Physician or staff with licensing board actions or expired credentials
• Payor contracts that contain change-of-control provisions requiring consent before assignment
• Violation of the Corporate Practice of Medicine doctrine in states like Texas
• Missing or deficient HIPAA compliance programs
• Improper business arrangements that raise Anti-Kickback concerns

Understanding the Corporate Practice of Medicine doctrine in Texas is particularly important when the buyer is a non-physician or a private equity-backed entity.

How do buyers evaluate compliance risk?

Evaluating compliance risk involves more than reviewing policies on paper. A thorough compliance review should analyze:

• Whether the entity’s billing patterns are consistent with peer benchmarks
• Whether documentation supports the level of service billed
• Whether physician supervision requirements were satisfied
• Whether any third-party audits or OIG work plan items are relevant to the entity’s practice area

Our resource on evaluating compliance risks in a healthcare acquisition provides a practical framework for this analysis.

Stock Purchase vs. Asset Purchase: Which Structure Is Right for Your Healthcare Deal?

This is one of the most common questions in healthcare M&A. The right answer depends on your priorities as a buyer or seller, the nature of the practice, and the regulatory environment involved.

For a comprehensive breakdown, see our detailed comparison of asset versus stock purchase structures in healthcare.

What Role Does a Management Services Organization Play in a Stock Deal?

In many healthcare transactions, particularly those involving non-physician buyers, the deal structure incorporates a Management Services Organization (MSO). This is especially common in Texas, where the Corporate Practice of Medicine doctrine restricts non-physicians from directly owning medical practices.

An MSO is a separate business entity that provides administrative and management services to a physician-owned professional entity. In a stock deal, the buyer may acquire the MSO while a licensed physician retains ownership of the professional corporation.

This structure must be carefully designed to comply with Texas law. Our resources on Texas Management Services Organizations and the MSO model in healthcare explain how this structure works and what legal requirements apply.

If you are a non-physician considering a healthcare acquisition, also review our guide on the Corporate Practice of Medicine doctrine for non-physician buyers in Texas.

What Are the Most Common Mistakes in Healthcare Stock Purchase Agreements?

Deals fall apart, or worse, succeed on paper but fail operationally, because of avoidable mistakes. Here are the errors we see most frequently.

Skipping or rushing due diligence

Time pressure in competitive deals sometimes causes buyers to shortcut due diligence. In healthcare, that is a serious risk. A billing irregularity discovered three years after closing can become an eight-figure liability. Invest the time upfront.

Using a generic SPA template

Standard business purchase agreements are not designed for healthcare. They lack the healthcare-specific representations, compliance warranties, and regulatory provisions that protect buyers and sellers in this space. Always use an attorney with healthcare M&A experience.

Ignoring payor contract change-of-control provisions

Many managed care and commercial insurance contracts include clauses requiring the insurer’s consent before a change in ownership takes effect. Missing these provisions can result in contract termination and sudden loss of revenue after closing.

Failing to address regulatory approvals in the closing timeline

Some healthcare transactions require regulatory notifications or approvals before they can close. Failing to build adequate time into the closing timeline can create legal exposure or delay the transaction.

Not structuring the indemnification for healthcare-specific risk

Standard indemnification periods are often too short for healthcare. Government investigations and CMS audits can surface long after a deal closes. Negotiate survival periods that reflect the regulatory risk profile of the specific entity.

See our resource on regulatory and compliance considerations in medical practice transactions for a deeper review of these risk factors.

How Does a Healthcare Attorney Add Value in a Stock Deal?

A healthcare attorney who understands both the legal and regulatory sides of a stock purchase does much more than review documents. The right attorney:

• Structures the deal to protect you from inherited liability
• Identifies regulatory risks that a general business attorney might miss
• Drafts or reviews representations and warranties specific to healthcare compliance
• Advises on whether the deal structure is compatible with Texas law, including CPOM restrictions
• Coordinates review of Medicare, Medicaid, and payor contract implications
• Negotiates indemnification provisions that reflect the actual risk profile of the transaction
• Flags licensing and credentialing issues before they become post-closing problems

If you are selling a practice, an experienced healthcare attorney also ensures that the representations you make in the SPA are accurate, complete, and defensible. Inaccurate reps made at closing can expose you to indemnification claims years after you have moved on.

Our firm founder Doris Dike brings deep healthcare law expertise to every transaction, ensuring both buyers and sellers have the guidance they need throughout the process. Learn more about our Texas healthcare M&A practice.

If you are located in a specific Texas market, we also serve clients in Houston, Dallas, Austin, San Antonio, and Frisco.

Special Considerations for Texas Healthcare Stock Purchases

How does Texas licensing law affect a stock deal?

Texas requires healthcare entities and individual providers to maintain active licenses and registrations. A change in ownership through a stock purchase does not automatically trigger a new licensing requirement for the entity, but individual practitioners must maintain their own licensure regardless of corporate changes.

The Texas Medical Board oversees physician licensing, and any acquisition should confirm that all supervising physicians hold current, unrestricted licenses. Our resources on Texas licensing defense and healthcare licensing requirements for Texas providers provide relevant background.

What about Texas Medicaid requirements?

The Texas Health and Human Services Commission administers the Texas Medicaid program. A change of ownership notification may be required, and the acquiring entity must ensure continued compliance with all HHSC enrollment and billing requirements.

Does the deal require antitrust review?

Larger healthcare transactions may trigger review under the Hart-Scott-Rodino Antitrust Improvements Act, requiring pre-merger notification to the Federal Trade Commission and the Department of Justice. While many physician practice acquisitions fall below the threshold, larger transactions involving hospital groups or multi-specialty organizations may require advance filings.

What Happens After a Healthcare Stock Purchase Closes?

Closing the deal is not the end. Post-closing obligations are especially important in healthcare transactions.

After a stock deal closes, buyers typically need to:

• Notify CMS and relevant state agencies of the ownership change as required
• Update payor credentialing files and provider records
• Review and update HIPAA policies and Business Associate Agreements
• Assess and implement a new or revised compliance program
• Address any transition services arrangements with the seller
• Review employment and contractor agreements for post-closing obligations

Post-closing integration is where many deals that looked good on paper begin to show cracks. Proactive planning for the post-closing period is as important as the deal itself.

Our resource on selling your healthcare business addresses what sellers need to prepare for, and our guide on seven essential steps before you buy a healthcare practice helps buyers plan ahead.

Frequently Asked Questions About Stock Purchase Agreements in Healthcare

What is the main risk of a stock purchase in healthcare?

The primary risk is inherited liability. When you acquire a company’s stock, you take on everything the company has ever done, including undisclosed billing errors, compliance violations, pending investigations, and contractual obligations. A thorough due diligence process and well-structured indemnification provisions are essential to manage this risk. See our detailed stock purchase agreement resources for more.

Can a non-physician buy a medical practice through a stock purchase in Texas?

Not directly through ownership of the professional entity due to Texas’s Corporate Practice of Medicine doctrine. However, a non-physician can often structure the acquisition using an MSO, where the business entity is acquired and a physician retains ownership of the professional corporation. Review our guide on non-physicians owning a medical practice and the MSO guide for non-physicians.

Do Medicare and Medicaid provider numbers transfer in a stock deal?

In a stock deal, the legal entity remains the same, so the provider number stays with the entity. However, CMS requires notification of ownership changes, and failure to notify within the required timeframe can create compliance issues. The specific requirements depend on the type of provider and the structure of the transaction. The CMS provider enrollment guidance outlines the applicable notification requirements.

How long does a healthcare stock purchase transaction typically take?

Healthcare stock purchases typically take between 60 and 180 days from letter of intent to closing, depending on the complexity of due diligence, regulatory requirements, and negotiation timelines. Deals involving Medicaid provider transitions, payor consent requirements, or regulatory approvals tend to take longer. Our overview of what a letter of intent covers explains how the deal timeline begins.

What is a representation and warranty insurance policy in healthcare M&A?

Representation and warranty (R&W) insurance is a policy that covers losses arising from breaches of the seller’s representations and warranties in the purchase agreement. In healthcare deals, R&W insurance has become increasingly common because it allows buyers to seek recovery from an insurer rather than pursuing the seller directly, which can preserve the business relationship and accelerate deal timelines. It does not replace thorough due diligence, but it provides an additional layer of protection for buyers.

What should I look for in payor contracts during due diligence?

You should specifically look for change-of-control provisions, termination rights triggered by ownership changes, and any assignment restrictions. Many commercial insurance contracts allow the insurer to terminate the agreement if ownership changes without prior consent. Missing these clauses can result in the loss of significant revenue streams immediately after closing.

How are earn-outs structured in healthcare stock purchase agreements?

Earn-outs tie a portion of the purchase price to future performance metrics, such as revenue targets or patient volume thresholds, measured over a defined period after closing. They are used when buyers and sellers disagree on valuation. In healthcare, earn-out metrics must be structured carefully to avoid creating incentives that could implicate the Anti-Kickback Statute or other fraud and abuse laws. See our resource on structuring earn-out agreements in healthcare.

What happens to malpractice coverage in a stock deal?

Malpractice insurance for individual practitioners does not transfer through a corporate stock purchase. Each physician or provider must maintain their own professional liability coverage. The entity itself may carry separate general liability or umbrella coverage. Buyers should review all existing insurance policies during due diligence and ensure adequate coverage is in place at and after closing.

Can a stock purchase agreement be renegotiated after signing?

An SPA is a binding contract once signed, but parties can negotiate amendments by mutual agreement. Material adverse change clauses in the SPA may give a buyer the right to exit or renegotiate if a significant negative event occurs between signing and closing. Whether and how an SPA can be renegotiated depends on its specific terms and the circumstances involved.

Do I need a separate compliance attorney for a healthcare stock deal?

Not necessarily separate, but you absolutely need an attorney who understands healthcare compliance as part of the transaction team. A healthcare M&A attorney with compliance expertise can address both the transactional and regulatory dimensions without requiring you to coordinate between multiple firms. This is one reason to work with a firm that focuses exclusively on healthcare law rather than a general business practice. Explore our full range of healthcare legal services to see how we approach transactions holistically.

Ready to Move Forward With Your Healthcare Transaction?

Whether you are buying a physician practice, selling a multi-location healthcare group, or evaluating a complex acquisition structure, a stock purchase agreement in healthcare is not a document to navigate alone.

The stakes are high. The regulatory landscape is complex. And the consequences of a poorly structured deal can follow you for years.

At Dike Law Group, healthcare law is all we do. We represent physicians, healthcare entrepreneurs, and healthcare organizations across Texas and beyond in transactions of every size. From due diligence to closing, we protect your interests, identify risks before they become liabilities, and help you structure deals that work on paper and in practice.

If you are evaluating a healthcare stock purchase or preparing to sell your practice, we invite you to schedule a consultation. Our team is here to give you direct, practical guidance from attorneys who understand healthcare at every level.

Contact Dike Law Group today at (972) 290-1031 or visit us at 6160 Warren Parkway, Ste. #100, Frisco, TX 75034. You can also find us on Google Maps.

Explore more of our resources on healthcare business transactions, including our guides on asset purchase agreements, contract negotiations in medical practice deals, and key metrics for valuing a medical practice in Texas.

Disclaimer: This article is intended for general educational purposes only and does not constitute legal advice. Laws and regulations governing healthcare transactions vary by jurisdiction and change frequently. For guidance specific to your situation, please consult a qualified healthcare attorney.